ArticleOne health (Amsterdam, Netherlands)2026
Evolution of foodborne disease surveillance in China: A 32-year journey from monitoring to early warning.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bombyx mori-Hosted Cordyceps militaris Polysaccharides: Structural Characterization and Antibacterial Activity of Native and Sulfated Derivatives.Chemistry & biodiversity · 2026Article
- Application of mNGS in traceability investigation of foodborne disease outbreaks caused byFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
China's foodborne disease (FBD) surveillance system was implemented later than those in most developed countries. However, in the past 32 years, it has undergone improvements: from pilot projects to full coverage; from a passive mode to an active one; from localized development to the integration of international standards; and from a single function to a comprehensive system. During this process, China's health administrative departments have adjusted their regulatory departments and functions for FBDs in response to evolving epidemiological patterns of FBD. Simultaneously, they have used a phased, step-by-step approach to promote the use of whole genome sequencing (WGS) technology, according to the level of regional economic development, to facilitate FBD traceability. However, the system must be further improved in terms of traceability capabilities, multi-departmental collaboration, and data sharing mechanisms. At various historical stages, FBD outbreaks in China have shown distinct regional characteristics, and the spectrum of common pathogenic bacteria in China differs from those in the Europe Union (EU) and the United States. In China, diseases caused by microorganisms such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.